These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 4004483

  • 1. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
    Theintz GE, Sizonenko PC.
    Arch Fr Pediatr; 1985 Mar; 42(3):211-7. PubMed ID: 4004483
    [Abstract] [Full Text] [Related]

  • 2. Response to treatment of congenital adrenal hyperplasia in infancy.
    Young MC, Hughes IA.
    Arch Dis Child; 1990 Apr; 65(4):441-4. PubMed ID: 2346339
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [17-hydroxyprogesterone, testosterone and androstenedione in treated congenital adrenogenital syndrome].
    von Schnakenburg K, Bidingmaier F, Knorr D.
    Monatsschr Kinderheilkd (1902); 1977 May; 125(5):579-80. PubMed ID: 876244
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Plasma progesterone, 17-hydroxyprogesterone, androstenedione and testosterone in prepubertal, pubertal and adult subjects with congenital virilizing adrenal hyperplasia as indicators of adrenal suppression.
    Lee PA, Urban MD, Gutai JP, Migeon CJ.
    Horm Res; 1980 May; 13(6):347-57. PubMed ID: 7196877
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Elevated 17-hydroxyprogesterone and testosterone in a newborn with 3-beta-hydroxysteroid dehydrogenase deficiency.
    Cara JF, Moshang T, Bongiovanni AM, Marx BS.
    N Engl J Med; 1985 Sep 05; 313(10):618-21. PubMed ID: 3160950
    [No Abstract] [Full Text] [Related]

  • 11. [Congenital adrenal hyperplasia due to blockade of 3-beta-hydroxysteroid dehydrogenase].
    Gendrel D, Chaussain JL, Roger M, Job JC.
    Arch Fr Pediatr; 1979 Sep 05; 36(7):647-55. PubMed ID: 161161
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Medroxyprogesterone acetate. Contributive treatment in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in children].
    La Selve H, Sempé M, Morel Y, Forest MG, de Peretti E, David M.
    Arch Fr Pediatr; 1985 Sep 05; 42(7):511-6. PubMed ID: 2935112
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Alternate day prednisone therapy in congenital adrenal hyperplasia: adrenal androgen suppression and normal growth.
    Linder B, Feuillan P, Chrousos GP.
    J Clin Endocrinol Metab; 1989 Jul 05; 69(1):191-5. PubMed ID: 2543690
    [Abstract] [Full Text] [Related]

  • 19. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
    Charmandari E, Matthews DR, Johnston A, Brook CG, Hindmarsh PC.
    J Clin Endocrinol Metab; 2001 Oct 05; 86(10):4679-85. PubMed ID: 11600525
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.